ReviewInternational journal of nanomedicine2025
Zinc Doped Synthetic Polymer Composites for Bone Regeneration: A Promising Strategy to Repair Bone Defects.
Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Bioinspired and living multiscale composites for regenerative medicine in the treatment of surgical site infections.Journal of nanobiotechnology · 2026Review
- Advancements in zinc oxide nanofibers for enhanced rehabilitation and injury recovery: mechanisms, applications, and future directions.Journal of biological engineering · 2025Review
- Biofabrication of zinc-reinforced PLA scaffolds by FDM for bone tissue engineering.Regenerative biomaterials · 2025Article
- Zinc oxide nanoparticle chelated phosphocreatine-grafted chitosan composite hydrogels for enhancing osteogenesis and angiogenesis in bone regeneration.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zinc-doped synthetic polymer composites are a potential approach for bone regeneration, effectively meeting the urgent requirement for efficient bone repair materials. This review critically examines recent advancements in zinc-doped synthetic polymer composites for bone regeneration, with a focus on their synthesis methods, material properties, biological interactions, and potential clinical applications. The primary findings indicate that adding zinc to synthetic polymers, such as poly (lactic-co-glycolic acid), polycaprolactone, and polyethylene glycol, enhances their mechanical strength, bioactivity, and biocompatibility. Those composite materials enable the regulated release of zinc, which stimulates cellular responses crucial for bone repair. The importance of this technique lies in its ability to give a versatile framework that promotes the regeneration of bone tissue, presenting a new alternative for patients with bone abnormalities and enhancing clinical results. Despite these advantages, Zn-doped polymer composites need to overcome challenges including high Zn concentration toxicity and altered degradation kinetics and changes in mechanical properties for optimized clinical success. Moreover, homogeneous Zn distribution within polymer matrices stands as an essential requirement to accomplish both stable bioactivity properties and uniform mechanical characteristics. The use of advanced fabrication methods will help overcome pelletization issues to improve the therapeutic application of Zn-doped polymer composites in bone tissue regeneration. This review is intended to provide a valuable resource for future research, contributing to the advancement of innovative therapies for bone regeneration. It facilitates the development of innovative solutions in regenerative medicines and bone repair by emphasizing the prospective role of zinc-doped polymers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.